The amniotic epithelium is in direct contact with the amniotic fluid and has tight junctions. The amniotic tight junctions function as a barrier to restrict fluid flux via the amniotic membrane during midpregnancy in the mouse. However, during late pregnancy, amniotic fluid volume significantly decreases in association with the disruption of amniotic tight junctions. The disruption of amniotic tight junctions is caused by apoptosis in the amniotic epithelium on Embryonic Day 17 (E17). In this study, we examine the molecular mechanisms underlying apoptosis of the amniotic epithelium of the mouse. We found that from E16, the number of activated macrophages that express high levels of NOS2 and tumor necrosis factor (TNF) increase in amniotic fluid. TNF receptor type 1 (TNFR1) was detectable from E16 onward. On E17, amniotic epithelial cells expressing TNFR1 became TUNEL positive, suggesting that TNF/ TNFR1 signaling may initiate apoptosis. To further confirm the role of TNF/TNFR1 signaling, WP9QY, a TNFR1 antagonist, was injected into the amniotic cavity and was found to significantly reduce the numbers of apoptotic cells in the E17 amniotic epithelium. Furthermore, dehydroxymethylepoxyquinomicin, a specific nuclear factor-kappa B inhibitor, was found to inhibit TNF production in macrophages and amniotic apoptosis in vivo. Finally, we showed that injection of TNF into the amniotic cavity induces early onset of apoptosis. These results indicate that amniotic apoptosis is induced by the TNF pathway via TNFR1 expressed in the amniotic epithelial cells and that activation of macrophages may trigger amniotic apoptosis. amniotic membrane, apoptosis, macrophage, TNF, TNF receptor type I
INTRODUCTION
The amniotic membrane encapsulates amniotic fluid and secures the intra-amnion environment for the fetus during pregnancy. The amniotic epithelium is the innermost layer of the amniotic membrane and is in direct contact with the amniotic fluid. We recently reported that amniotic epithelium has tight junctions that function as a barrier to restrict fluid flux via the amniotic membrane during midpregnancy in the mouse [1] . During late pregnancy in the mouse, amniotic fluid volume significantly decreases. This reduction in fluid volume is associated with the disruption of amniotic tight junctions and increased numbers of apoptotic cells in the amniotic epithelium. Similar increases in apoptotic cells in the amniotic epithelium are also observed in human near-term pregnancy [2] [3] [4] . In particular, high levels of apoptotic cells are detected in the ruptured amniotic membranes relative to intact membranes. The levels of apoptotic cells also increase in cases of preterm premature rupture of fetal membrane caused by intrauterine infections, such as chorioamnionitis [2, 5] . The apoptosis of amniotic epithelial cells triggers weakening of the amniotic membrane by upregulation of matrix metalloproteinase 2 [6, 7] . These reports suggest that apoptosis of amniotic epithelial cells is associated with the onset of rupture of fetal membranes during the process of labor.
Apoptosis is the process of programmed cell death and involves characteristic morphological changes, such as membrane blebbing, loss of cell membrane symmetry and attachment, cell shrinkage, nuclear fragmentation, chromatin condensation, and chromosomal DNA fragmentation. Apoptosis in amniotic epithelium has been reported to be induced by death receptors [8] . Six types of death receptors have been identified, and tumor necrosis factor receptor type 1 (TNFR1) is a representative death receptor [9, 10] . TNFR1 binds to its specific ligands, which are linked to TNF, and activates the intracellular apoptosis pathway via activation of caspase 3 [11, 12] . TNFR1 has been identified in amniotic membranes along with TNF in amniotic fluid [13, 14] . Interestingly, the levels of TNF are increased in amniotic fluid by intrauterine infections, such as chorioamnionitis [15] [16] [17] . Higher TNF levels in amniotic fluid have been noted in patients undergoing spontaneous delivery with labor than those undergoing cesarean delivery without labor [18, 19] . Further, intra-amniotic injection of TNF induces preterm labor in rhesus monkeys [20] . In an ex vivo model, TNF treatment of the human fetal membrane was found to promote activation of caspases 2, 3, 8, and 9, which are known to function as initiators and effectors of caspases in apoptosis [21] . These reports suggest that TNF signaling triggers the apoptosis of fetal membranes.
In this study, we aimed to determine whether TNF signaling triggered by the activation of macrophages via TNFR1 induces apoptotic changes in mouse fetal membranes in vivo. In our mouse model, amniotic apoptosis is initiated between Embryonic Day 16 (E16) and E17. TNFR1 becomes observable in the amniotic epithelium at E16. Activation of macrophages also occurs during E16, which leads to an increase in the TNF level in amniotic fluid. Administration of either dehydroxymethylepoxyquinomicin (DHMEQ; nuclear factor-kappa B [NFKB] inhibitor) or WP9QY (TNFR1 antagonist) significantly decreased the number of apoptotic cells. Furthermore, administration of TNF into amniotic fluid induced the apoptosis of amniotic membranes. To our knowledge, this is the first study to report that apoptosis is induced in vivo via the TNFR1/TNF pathway in the amniotic epithelial cells during pregnancy.
MATERIALS AND METHODS

Animals
Pregnant Institute of Cancer Research (ICR) mice were purchased from Japan SLC Inc. (Shizuoka, Japan). The day on which a vaginal plug was detected in the mice was designated as E0. In each of the experiments, the dissected amniotic membranes from the yolk sac were washed with 0.5 mM CaCl 2 and 0.5 mM MgCl 2 containing PBS (mPBS) and then used immediately. All animal protocols used in the present study were approved by the Animal Resource Committee of the School of Medicine, Keio University.
Materials
WP9QY was purchased from Calbiochem (La Jolla, CA). DHMEQ was chemically synthesized in our lab as described previously [22] . N-benzyloxycabonyl-Val-Ala-Asp-fluoromethylketone (Z-VAD-FMK) was purchased from Enzo Life Sciences (Farmingdale, NY). TNF was purchased from PeproTech (Rocky Hill, NJ). Other chemicals were purchased from SigmaAldrich (St. Louis, MO). The following antibodies were used as primary antibodies for immunological studies: rabbit polyclonal antibodies against TNFR1 (Abcam, Cambridge, U.K.) and against active caspase 3 (Promega, Madison, WI), or mouse monoclonal antibodies against occludin (Invitrogen/ Zymed Laboratories, San Francisco, CA). Secondary Alexa Fluor 488-conjugated goat anti-rabbit and Alexa Fluor 546-conjugated goat anti-mouse antibodies were purchased from Molecular Probes (Eugene, OR). An annexin V-fluorescein staining kit was purchased from Wako Pure Chemical Industries (Osaka, Japan). The TUNEL assay was performed using the DeadEnd Fluorometric TUNEL System (Promega).
Immunostaining
The amniotic membrane was fixed with methanol for 10 min at À208C and then in 1% paraformaldehyde in mPBS (pH 7.4) for 10 min at 48C. The fixed amniotic membrane was permeabilized with 0.2% Triton X-100 in mPBS (pH 7.4) for 5 min and then incubated with mPBS containing 5% bovine serum albumin as a blocking solution to saturate nonspecific sites of antibody binding. The amniotic membrane was then sequentially treated as follows: the membrane was exposed to primary antibodies for 1.5 h at room temperature in a blocking solution, followed by washing and exposure to secondary antibodies for 1 h at room temperature in a blocking solution. Controls were treated in the same way, except that the primary antibodies were not used. Images of the stained sections were obtained by fluorescence microscopy (BX-51; Olympus, Tokyo, Japan) or by confocal laser scanning microscopy (LSM510; Zeiss, Oberkochen, Germany).
Detection of Apoptotic Cells
Apoptosis was detected using the annexin V-fluorescein kit and TUNEL detection kit, according to the manufacturer's instructions. For the annexin Vfluorescein labeling assay, the amnion was washed with a binding buffer and then immersed in the binding buffer containing annexin V-fluorescein for 10 min in the dark at room temperature. The excess unbound annexin Vfluorescein was removed by washing with the binding buffer. The samples were then fixed for immunostaining. For the TUNEL assay, the fixed amnion was immersed in terminal deoxynucleotidyl transferase buffer containing deoxynucleotidyl transferase and fluorescein isothiocyanate-labeled dUTP, incubated in a humid atmosphere at 378C for 60 min, and subsequently immunostained.
Analysis of Macrophages in Amniotic Fluid
The density of macrophages in the amniotic membrane was measured using a hemocytometer in combination with immunostaining of F4/80 (BioLegend, San Diego, CA), a representative macrophage marker. The amniotic fluid volume was measured by absorption of the fluid on filter paper. The total number of amniotic macrophages per fetus was calculated from the average of the macrophage density and the fluid volume.
Quantitative Real-Time PCR
Quantitative real-time PCR was performed by the procedure described previously [23] . Briefly, total RNA of macrophages was extracted using an RNeasy Mini kit (Qiagen Inc., Valencia, CA) according to the manufacturer's instructions. Reverse transcriptions were performed using MultiScribe reverse transcriptase (Applied Biosystems, Foster City, CA). Quantitative real-time PCR was performed in a 7300 Fast Real-Time PCR System (Applied Biosystems) by using SYBR Green PCR Master Mix (Applied Biosystems). GAPDH primers were used to normalize samples. The oligonucleotide primers used were the inducible nitric oxide synthase (iNOS, NOS2)-specific primer pairs 5 0 -AAAGTGACCTGAAAGAGGAAAAGGA-3 0 (forward) and 5 0 -TTGGTGACTCTTAGGGTCATCTTGTA-3 0 (reverse); TNF-specific primer pairs 5 0 -TGTCTACTCCCAGGTTCTCTTCAAG-3 0 (forward) and 5 0 -TGACTTTCTCCTGGTATGAGATAGCA-3 0 (reverse); and internal control GAPDH-specific primer pairs 5 0 -GAGCGAGACCCCACTAACATC-3 0 (forward) and 5 0 -GCGGAGATGATGACCCTTTT-3 0 (reverse).
Intraperitoneal Administration of DHMEQ
DHMEQ is soluble in dimethyl sulfoxide at a concentration of 10 mg/ml. The DHMEQ solution was administered intraperitoneally with a 27-gauge needle to E15 pregnant mice daily for 2 days (8 mg/kg per day). The amniotic membranes and amniotic fluid, which contains macrophages, were extracted 2 days after the administration of DHMEQ. Specimens obtained from injections of pregnant mice with DMSO were designated as the vehicle group.
Organ Culture of Amniotic Membrane and Apoptosis Induction
The amniotic membrane was removed on E16 and immersed in Dulbecco modified Eagle medium (DMEM)/F-12 (GIBCO-BRL, Grand Island, NY) containing 0.4% agarose and chilled on ice for gelification. Amniotic membranes immobilized with agarose gel were immersed in DMEM/F-12 containing 10% fetal bovine serum, 100 U/ml penicillin, and 100 lg/ml streptomycin.
The immobilized amniotic membranes were pretreated with actinomycin D to enhance the apoptosis signal at a concentration of 0.2 lg/ml for 1 h at 378C, and then they were washed five times with the culture medium. TNF was added to the culture medium at a concentration of 25 ng/ml, and the amniotic membranes were cultured for 10 h at 378C. WP9QY (final concentration, 40 lM) or Z-VAD-FMK (final concentration, 50 lM) were added to the medium 1.5 h before addition of TNF.
Injection of WP9QY and TNF into Amniotic Cavity
WP9QY and TNF were found to be soluble in PBS at concentrations of 2 mM and 2 lg/ml, respectively. Pregnant mice at E15.5 (TNF) or E16 (WP9QY) were anesthetized, and the uterine horn was gently pulled. Volumes of 5 ll of the WP9QY or TNF solutions were injected through the exposed uterine wall into each amniotic cavity using a 33-gauge needle. The uterine horn was returned to the abdominal cavity, and the abdominal muscle wall and skin were closed. The amniotic membranes were extracted 16 h after injection (TNF) or 1 day after injection (WP9QY). Specimens originating from pregnant mice injected with PBS were treated in the same manner as the specimens obtained from the mice of the vehicle group.
Statistics
Data are expressed as mean 6 SD. The statistical significance was verified using the Student t-test (minimum, n ¼ 5 originating from different pregnant mice) and is indicated by asterisks.
RESULTS
Apoptosis Is Induced in the Amniotic Epithelium During Pregnancy
We have previously demonstrated that the process of apoptosis occurs in specific regions of the amniotic epithelium that are associated with dynamic changes in amniotic tight junctions in E17 [1] . To elucidate the precise timing of when the apoptotic changes start, the mouse amniotic membranes between E16 and E17 were examined by annexin V-fluorescein labeling as well as the TUNEL assay [24, 25] . Positive reactions to annexin V-fluorescein labeling and TUNEL assays were not observed at E16 and E16.5, but AMNIOTIC APOPTOSIS VIA TNF PATHWAY were detected in a dispersed pattern at E17 (Fig. 1) . Activation of caspase 3 precedes the process of apoptosis detected by annexin V-fluorescein labeling or the TUNEL assay [26] . The immunofluorescence with anti-active caspase 3 revealed that the active caspase 3 was not observed at E16 but was observed at E16.5, and it increased at E17. These data indicate that amniotic apoptosis may be initiated between E16 and E17.
TNFR1-Expressing Cells Appear in the Amniotic Epithelium Coincidentally with Apoptosis
We next examined whether TNFR1 is expressed in the amniotic epithelium by immunofluorescence. TNFR1-expressing cells were not observed at E15 but appeared at E16, and they were increased at E17. Localization of TNFR1 was indicated by a dotted pattern on the apical and lateral membranes of amniotic epithelial cells (Fig. 2, A-C) . At E17, some of the TNFR1-expressing cells in the amniotic membranes were TUNEL positive (Fig. 2D) .
Levels of Macrophages Are Increased and Activated at E16
Macrophages are known to induce apoptosis in several different organs [27] [28] [29] [30] . To examine whether the activated macrophages induce the process of apoptosis observed in the amniotic epithelium during late pregnancy, we first examined the number of macrophages in the amniotic fluid. This is assessed by the density of macrophages and amniotic fluid volume. The density and the total number of macrophages were found to be increased between E15 and E16, although amniotic fluid significantly decreased between E16 and E17 (Fig. 3, A-C) . We next examined whether these macrophages are activated. The mRNA expression of NOS2 and TNF was examined separately by quantitative real-time PCR. NOS2 mRNA in the isolated macrophages exponentially increased from E15 to E17 (Fig. 3D) . TNF mRNA expression also increased in the same manner.
DHMEQ, an Inhibitor of NFKB, Interferes with Activation of Macrophages and Decreases the Numbers of Apoptotic Cells In Vivo
It has been reported that macrophages in the amniotic fluid can be activated by surfactant protein A (SP-A), secreted from fetal lung, via the NFKB pathway [31] . In this study, DHMEQ, a specific inhibitor of NFKB, was administrated to pregnant mice at Gestational Day 15 to block the activation of macrophages in amniotic fluid. As expected, we found that DHMEQ significantly reduces the expression levels of NOS2   FIG. 1 . Induction of apoptosis in amniotic epithelium during mouse pregnancy. Apoptotic changes of amniotic epithelium between E16, E16.5, and E17 were detected by annexin V-fluorescein labeling, TUNEL assays, and immunostaining with anti-active caspase 3 antibodies (green). Images stained with 4 0 ,6 0 -diamidino-2-phenylindole (DAPI; blue) and with anti-occludin antibodies (red) were merged to represent nuclei and interfaces between amniotic epithelial cells, respectively. Bars ¼ 20 lm. and TNF in the macrophages (Fig. 4A) . Furthermore, the number of TUNEL-positive apoptotic cells in amniotic epithelium was found to decrease upon administration of DHMEQ (Fig. 4, B and C) .
FIG. 2. Expression of TNFR1 in amniotic epithelium. Amniotic membranes on E15 (A), E16 (B)
,
WP9QY, a TNFR1 Antagonist, Decreases the Numbers of Apoptotic Cells in Amniotic Epithelium Both In Vitro and In Vivo
To further examine whether TNFR1 is involved in the apoptosis of amniotic epithelial cells, WP9QY, a TNF antagonist, was administered both in vitro and in vivo. For the in vitro experiments, the amniotic membranes originating from E16 were organ cultured in the presence of TNF. In this model, amniotic membranes were pretreated with actinomycin D to enhance the apoptosis signal of TNF [32, 33] . In the presence of TNF, TUNEL-positive and active caspase 3-positive epithelial cells were observed (Fig. 5, left column) . The TUNEL-positive cells also showed expression of TNFR1. Preincubation with WP9QY significantly decreased the numbers of TUNEL-positive cells or active caspase 3 ( Fig  5, middle column) . The numbers of TUNEL-positive cells were also found to be decreased in the amniotic membranes treated with Z-VAD-FMK, a broad-spectrum caspase inhibitor (Fig. 5, right column) . Treatment with WP9QY or Z-VAD-FMK did not alter the expression of TNFR1. It is notable that the slightly positive reactions to active caspase 3 were observed in parts of amniotic epithelial cells in the Z-VAD-FMK-treated amniotic epithelium, but not in the WP9QY-treated epithelium.
For in vivo experiments, WP9QY was injected into the amniotic cavity of E16 pregnant mice. One day after the injection, the amniotic membranes treated with vehicle showed TUNEL-positive cells and activation of caspase 3 to an extent similar to the untreated E17 membranes (Fig. 6A) . However, in the amniotic membrane treated with WP9QY, TUNEL-positive apoptotic cells were sparsely dispersed on the amniotic epithelium, and the positive reaction of active caspase 3 became weak. The number of apoptotic cells significantly decreased to 20% of the numbers observed for the vehicle group (Fig. 6B) .
Injection of TNF into Pregnant Mouse Induces Apoptosis in the Amniotic Epithelium
We examined whether apoptosis of amniotic epithelial cells is induced by an injection of TNF. TNF was injected into pregnant mice at E15.5, and the amniotic membranes were extracted 16 h after injection. TUNEL-positive epithelial cells were detected in these amniotic membranes (Fig. 6C) . The TUNEL-positive apoptotic epithelial cells:total amniotic epithelial cells ratio was 0.73% 6 0.41% (n ¼ 10). Contemporary, Taken together, we conclude that TNF signaling via TNFR1 induces apoptosis in the amniotic epithelium during late pregnancy in the mouse.
DISCUSSION
TNFR1 is a well-known death receptor for apoptosis, and the binding of TNF to TNFR1 induces apoptosis by activation of caspase 3 [11, 12] . In this study, we investigated whether apoptosis occurring in mouse amniotic epithelium is driven via the TNF/TNFR1 pathway. During mouse pregnancy, the expression of TNFR1 was detected in portions of amniotic epithelial cells on E16. The TNFR1-expressing cells gradually increased after E16, which was coincident with increases in the levels of activated macrophages expressing TNF in amniotic fluid. Indeed, a fraction of TNFR1-expressing cells undergoes apoptosis in E17 amniotic epithelium. Apoptosis in the amniotic epithelium was also identified on E16.5 by immunostaining of the active form of caspase 3 ahead of loss of plasma membrane integrity and nuclear fragmentation detected by annexin V-fluorescein labeling and TUNEL assays. It has been reported that the TNF/TNFR1 pathway activates caspase 3 for apoptosis [21] . These results suggest that the apoptosis pathway may be induced by TNF from activated macrophages through TNFR1 of amniotic epithelial cells between E16 and E17. To determine whether the TNF/TNFR1 pathway directly initiates apoptosis of amniotic epithelial cells, we investigated the induction of apoptosis in the amniotic epithelium in vitro and in vivo by using WP9QY, which inhibits binding of TNF to TNFR1 [34] . TNF treatment was found to induce apoptosis in TNFR1-expressing epithelial cells in organ-cultured E16 amniotic membrane. Such apoptosis did not occur in E15 amniotic membranes, which do not express TNFR1 (data not shown). Apoptosis induced by TNF treatment was blocked by pretreatment with WP9QY. WP9QY also was found to block the activation of caspase 3. Similar results were obtained by application of Z-VAD-FMK, the broad-spectrum caspase inhibitor [35] . The injection of WP9QY into the amniotic cavity decreased the numbers of apoptotic cells in the amniotic epithelium and blocked the activation of caspase 3. On the other hand, TNF injection into the amniotic cavity advanced the induction of apoptosis of amniotic epithelial cells. These results suggest that apoptosis in the amniotic epithelium is initiated through the TNF/TNFR1 pathway.
Apoptosis of amniotic epithelial cells could be blocked by the inhibition of macrophage activation, because TNF is induced through NFKB in activated macrophages [31, 36] . DHMEQ, a specific inhibitor of NFKB, inhibits activation of macrophages, such as upregulation of NOS2 and TNF [37] . Therefore, in this study, DHMEQ was administered to pregnant mice to block the activation of macrophages as well as to induce upregulation of TNF. As expected, DHMEQ decreased the expression of TNF in macrophages. DHMEQ administration also decreased the numbers of apoptotic cells in the amniotic epithelium. These results suggest that activation of macrophages induces apoptosis of amniotic epithelial cells. Macrophages are known to induce apoptosis in several different organs, such as the lung, liver, eye, and small intestine [27] [28] [29] [30] . Apoptosis caused by macrophages is often induced via the TNFR1/TNF pathway [29, 38, 39] . The involvement of macrophages in apoptosis has been also reported in trophoblasts of placenta during pregnancy [40, 41] . It has been reported that coculture of a trophoblast cell line with activated macrophages induces apoptosis via TNF [42] . Another study using extravillous trophoblast hybrid cells has also shown that apoptosis induced by exogenous TNF or activated macrophages is inhibited by administration of TNFR1 antibodies [43] . In amniotic fluid, amniotic macrophages are activated by SP-A, and activated macrophages secrete proinflammatory cytokines into amniotic fluid [36] . These reports support our findings that amniotic epithelial apoptosis is initiated via the TNF/TNFR1 pathway in the presence of activated macrophages in amniotic fluid. 
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It is possible that unknown factors may contribute to induction of apoptosis either independently or in a manner that complements the TNF/TNFR1 pathway. In this study, WP9QY was found to be incapable of completely blocking apoptosis in vivo. On the other hand, in vitro apoptosis induced by TNF was blocked completely by actinomycin D treatment. In addition, TNF did not induce apoptosis without pretreatment of actinomycin D in in vitro organ cultures of amniotic membrane, although the in vivo injection of TNF into the amniotic cavity can induce apoptosis (data not shown). These results imply the presence of unknown factors that participate in the induction of apoptosis in the amniotic epithelium in vivo. The apoptosis pathway via death receptors includes the Fas-Fas ligand-mediated pathway [44] . In amniotic epithelium, both Fas and Fas ligand are expressed in the amniotic epithelium [3, 45] . However, the concentrations of Fas ligand in amniotic fluid were found to be decreased significantly near term, and the expression level of Fas does not differ between apoptotic and nonapoptotic cells [46, 47] . Other kinds of cytokines may contribute to the induction of apoptosis via the TNF/TNFR1 pathway. The combined application of TNF with interleukin 6 (IL6) and interferon-gamma (IFNG) enhances the inducibility of apoptosis [48, 49] . In addition, nitric oxide originating from activated macrophages may modulate apoptosis of amniotic epithelium [50] . The factors involved in induction of apoptosis of amniotic epithelial cells in vivo remain unclear, although the TNF/TNFR1 pathway has a key role in amniotic epithelial apoptosis during normal pregnancy.
We recently reported that the amniotic barrier functions to restrict the fluid flux via the amniotic membrane, which is lost after the disruption of amniotic tight junctions associated with apoptosis [1] . The disruption of amniotic tight junctions is also observed in human amniotic epithelium during late pregnancy [23] . The amniotic fluid contains several components that are known to induce term and labor. These components include SP-A, proinflammatory cytokines, and matrix metalloproteinase [19, 36, 51] . Loss of barrier function of amniotic epithelium by apoptosis would allow the effusion of amniotic fluid components into the amniotic subepithelial layer, placenta, and uterus. The effusion of amniotic fluid components may induce rupture of the fetal membrane to enhance the progression toward labor and delivery in late pregnancy.
We showed using a mouse model that apoptosis in amniotic epithelium is initiated via the TNF/TNFR1 pathway in late pregnancy and that activated macrophages may trigger this apoptotic pathway. There are several differences associated with parturition between mice and humans. Interestingly, it has been suggested that racial disparity in humans involving singlenucleotide polymorphisms of TNF is associated with rates of preterm birth [52] [53] [54] . Further investigation of the human amniotic membrane is required.
